The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

May. 23, 2014
Applicant:

Genomatica, Inc., San Diego, CA (US);

Inventors:

Benjamin Adelstein, San Diego, CA (US);

Robin E. Osterhout, San Diego, CA (US);

Mark J. Burk, San Diego, CA (US);

Assignee:

Genomatica, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 7/62 (2022.01); C12N 9/18 (2006.01); A61K 31/22 (2006.01); A61K 35/66 (2015.01); A61K 36/064 (2006.01); A23L 33/135 (2016.01); C12N 1/00 (2006.01); C12N 1/14 (2006.01); C12N 1/20 (2006.01); C07C 69/675 (2006.01); C12N 15/52 (2006.01); C12R 1/00 (2006.01); C12R 1/01 (2006.01); C12R 1/645 (2006.01);
U.S. Cl.
CPC ...
C12P 7/62 (2013.01); A23L 33/135 (2016.08); A61K 31/22 (2013.01); A61K 35/66 (2013.01); A61K 36/064 (2013.01); C07C 69/675 (2013.01); C12N 1/00 (2013.01); C12N 1/145 (2021.05); C12N 1/205 (2021.05); C12N 9/18 (2013.01); C12N 15/52 (2013.01); C12Y 101/011 (2013.01); C12Y 101/01035 (2013.01); C12Y 301/01067 (2013.01); C12Y 301/08001 (2013.01); A23V 2002/00 (2013.01); C07B 2200/05 (2013.01); C12R 2001/00 (2021.05); C12R 2001/01 (2021.05); C12R 2001/645 (2021.05); Y02P 20/10 (2015.11);
Abstract

Provided herein are non-naturally occurring microbial organisms having a pathway for production of (3R)-hydroxybutyl (3R)-hydroxybutyrate, wherein the organism can further include a (R)-1,3-butanediol pathway, a (3R)-hydroxybutyrate pathway, a (3R)-hydroxybutyryl-CoA pathway, an acetoacetate pathway, an acetoacetyl-CoA pathway, a (3R)-hydroxybutyl-ACP pathway, or an acetoacetyl-ACP pathway. Additionally provided are methods and processes for producing and isolating (3R)-hydroxybutyl (3R)-hydroxybutyrate using the microbial organisms, and various compositions having the (3R)-hydroxybutyl (3R)-hydroxybutyrate. Still further provided are methods of treating or preventing a disease, disorder or condition using the (3R)-hydroxybutyl (3R)-hydroxybutyrate produced by the microbial organisms of the invention.


Find Patent Forward Citations

Loading…